Millipore Sigma Vibrant Logo
Attenzione: Ci siamo trasferiti. Non è più possibile acquistare i prodotti Merck Millipore nel sito MerckMillipore.comPer saperne di più

553525 RAD51 Inhibitor, B02 - CAS 1290541-46-6 - Calbiochem

553525
Purchase on Sigma-Aldrich

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
1290541-46-6C₂₂H₁₇N₃O

Products

Numero di catalogoConfezionamento Qtà/conf
553525-25MG Bottiglia di vetro 25 mg
Description
OverviewA cell-permeable pyridinylvinyl-quinazolinone compound that is shown to specifically inhibit human RAD51 (IC50 = 27.4 µM). Does not affect RecA even at much higher concentration (~250 µM). Directly interacts with RAD51 (Kd = 5.6 µM), and disrupts its binding to DNA and nucleoprotein filament formation. Blocks double-strand break-induced homologous recombination and enhances sensitivity of cells to Cisplatin (Cat. No. 232120) and Mitomycin C (Cat. No. 47589), (Cat. No. 475820). Diminishes co-aggregate formation between RAD51-ssDNA filament and dsDNA. RAD51-Stimulatory Compound-1, RS-1 (Cat. No. 553510) is also available.
Catalogue Number553525
Brand Family Calbiochem®
Synonyms(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one
References
ReferencesHuang, F., et al. 2012. J. Med. Chem. 55, 3031.
Huang, F., et al. 2011. ACS Chem. Biol. 6, 628.
Product Information
CAS number1290541-46-6
FormLight yellow powder
Hill FormulaC₂₂H₁₇N₃O
Chemical formulaC₂₂H₁₇N₃O
Structure formula ImageStructure formula Image
Quality LevelMQ100
Applications
Biological Information
Purity≥98% by HPLC
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Ambient Temperature Only
Toxicity Regulatory Review
Storage +2°C to +8°C
Protect from Light Protect from light
Do not freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Packaging Information
Packaged under inert gas Packaged under inert gas
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Numero di catalogo GTIN
553525-25MG 04055977193749

Documentation

RAD51 Inhibitor, B02 - CAS 1290541-46-6 - Calbiochem MSDS

Titolo

Scheda di sicurezza (MSDS) 

RAD51 Inhibitor, B02 - CAS 1290541-46-6 - Calbiochem Certificati d'Analisi

TitoloNumero di lotto
553525

Riferimenti bibliografici

Panoramica delle referenze
Huang, F., et al. 2012. J. Med. Chem. 55, 3031.
Huang, F., et al. 2011. ACS Chem. Biol. 6, 628.
Scheda tecnica

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision27-September-2013 JSW
Synonyms(E)-3-Benzyl-2-(2-(pyridin-3-yl)vinyl)quinazolin-4(3H)-one
DescriptionA cell-permeable pyridinylvinyl-quinazolinone compound that is shown to specifically inhibit human RAD51 (IC50 = 27.4 µM). Does not affect RecA even at much higher concentration (~250 µM). Directly interacts with RAD51 (Kd = 5.6 µM), and disrupts its binding to DNA and nucleoprotein filament formation. Blocks double-strand break-induced homologous recombination and enhances sensitivity of cells to Cisplatin (Cat. No. 232120) and Mitomycin C (Cat. No. 47589), (Cat. No. 475820). Diminishes co-aggregate formation between RAD51-ssDNA filament and dsDNA. RAD51-Stimulatory Compound-1, RS-1 (Cat. No. 553510) is also available.
FormLight yellow powder
Intert gas (Yes/No) Packaged under inert gas
CAS number1290541-46-6
Chemical formulaC₂₂H₁₇N₃O
Structure formulaStructure formula
Purity≥98% by HPLC
SolubilityDMSO (50 mg/ml)
Storage Protect from light
+2°C to +8°C
Do Not Freeze Ok to freeze
Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Toxicity Regulatory Review
ReferencesHuang, F., et al. 2012. J. Med. Chem. 55, 3031.
Huang, F., et al. 2011. ACS Chem. Biol. 6, 628.